1. Home
  2. LGND vs AFYA Comparison

LGND vs AFYA Comparison

Compare LGND & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • AFYA
  • Stock Information
  • Founded
  • LGND 1987
  • AFYA 1999
  • Country
  • LGND United States
  • AFYA Brazil
  • Employees
  • LGND N/A
  • AFYA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • LGND Health Care
  • AFYA Real Estate
  • Exchange
  • LGND Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • LGND 2.0B
  • AFYA 1.6B
  • IPO Year
  • LGND 1992
  • AFYA 2019
  • Fundamental
  • Price
  • LGND $122.40
  • AFYA $16.30
  • Analyst Decision
  • LGND Strong Buy
  • AFYA Sell
  • Analyst Count
  • LGND 8
  • AFYA 5
  • Target Price
  • LGND $144.71
  • AFYA $17.60
  • AVG Volume (30 Days)
  • LGND 139.7K
  • AFYA 118.6K
  • Earning Date
  • LGND 08-05-2025
  • AFYA 08-15-2025
  • Dividend Yield
  • LGND N/A
  • AFYA 1.51%
  • EPS Growth
  • LGND N/A
  • AFYA 41.32
  • EPS
  • LGND N/A
  • AFYA 1.31
  • Revenue
  • LGND $181,488,000.00
  • AFYA $599,363,389.00
  • Revenue This Year
  • LGND $18.41
  • AFYA $15.52
  • Revenue Next Year
  • LGND $18.87
  • AFYA $8.72
  • P/E Ratio
  • LGND N/A
  • AFYA $12.60
  • Revenue Growth
  • LGND 53.40
  • AFYA 15.70
  • 52 Week Low
  • LGND $81.74
  • AFYA $14.52
  • 52 Week High
  • LGND $129.90
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • AFYA 33.73
  • Support Level
  • LGND $111.72
  • AFYA $17.33
  • Resistance Level
  • LGND $115.53
  • AFYA $18.16
  • Average True Range (ATR)
  • LGND 3.46
  • AFYA 0.49
  • MACD
  • LGND 0.18
  • AFYA -0.10
  • Stochastic Oscillator
  • LGND 85.52
  • AFYA 13.64

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: